Work

Exposure-response (E-R) analysis of efficacy of pegvorhyaluronidase alfa (PEGPH20) in combination with nab-paclitaxel + gemcitabine (AG) in patients (Pts) with metastatic pancreatic ductal adenocarcinoma.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e15746

Authors: Yong Liu, Andrea J. Bullock, Julie Passarell, Sebastien Bihorel, Jill Fiedler-Kelly, Thomas C Heineman, Rose E. Sekulovich

Institutions: Halozyme Therapeutics (United States), Beth Israel Deaconess Medical Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947547971

Cites:

Cited by:

Related to: 10